These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 20299114)

  • 1. Development and validation of a bleeding risk model for patients undergoing elective percutaneous coronary intervention.
    Montalescot G; Salette G; Steg G; Cohen M; White HD; Gallo R; Steinhubl SR
    Int J Cardiol; 2011 Jul; 150(1):79-83. PubMed ID: 20299114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of intravenous enoxaparin in elective percutaneous coronary intervention in patients with renal impairment: results from the SafeTy and Efficacy of Enoxaparin in PCI patients, an internationaL randomized Evaluation (STEEPLE) trial.
    White HD; Gallo R; Cohen M; Steg PG; Aylward PE; Bode C; Steinhubl S; Montalescot G
    Am Heart J; 2009 Jan; 157(1):125-31. PubMed ID: 19081408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention 1-year results from the STEEPLE (SafeTy and efficacy of enoxaparin in percutaneous coronary intervention patients, an international randomized evaluation) trial.
    Montalescot G; Gallo R; White HD; Cohen M; Steg PG; Aylward PE; Bode C; Chiariello M; King SB; Harrington RA; Desmet WJ; Macaya C; Steinhubl SR;
    JACC Cardiovasc Interv; 2009 Nov; 2(11):1083-91. PubMed ID: 19926048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention.
    Montalescot G; White HD; Gallo R; Cohen M; Steg PG; Aylward PE; Bode C; Chiariello M; King SB; Harrington RA; Desmet WJ; Macaya C; Steinhubl SR;
    N Engl J Med; 2006 Sep; 355(10):1006-17. PubMed ID: 16957147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of anticoagulation regimens on sheath management and bleeding in patients undergoing elective percutaneous coronary intervention in the STEEPLE trial.
    Gallo R; Steinhubl SR; White HD; Montalescot G;
    Catheter Cardiovasc Interv; 2009 Feb; 73(3):319-25. PubMed ID: 19213086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial.
    White HD; Kleiman NS; Mahaffey KW; Lokhnygina Y; Pieper KS; Chiswell K; Cohen M; Harrington RA; Chew DP; Petersen JL; Berdan LG; Aylward PE; Nessel CC; Ferguson JJ; Califf RM
    Am Heart J; 2006 Dec; 152(6):1042-50. PubMed ID: 17161049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a prognostic risk score for major bleeding in patients undergoing percutaneous coronary intervention via the femoral approach.
    Nikolsky E; Mehran R; Dangas G; Fahy M; Na Y; Pocock SJ; Lincoff AM; Stone GW
    Eur Heart J; 2007 Aug; 28(16):1936-45. PubMed ID: 17575270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A risk score to predict bleeding in patients with acute coronary syndromes.
    Mehran R; Pocock SJ; Nikolsky E; Clayton T; Dangas GD; Kirtane AJ; Parise H; Fahy M; Manoukian SV; Feit F; Ohman ME; Witzenbichler B; Guagliumi G; Lansky AJ; Stone GW
    J Am Coll Cardiol; 2010 Jun; 55(23):2556-66. PubMed ID: 20513595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between heparins, glycoprotein IIb/IIIa antagonists, and coronary intervention. The Global Registry of Acute Coronary Events (GRACE).
    Brieger D; Van de Werf F; Avezum A; Montalescot G; Kennelly BM; Granger CB; Goodman SG; Dabbous OH; Agnelli G;
    Am Heart J; 2007 Jun; 153(6):960-9. PubMed ID: 17540196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incremental Value of Platelet Reactivity Over a Risk Score of Clinical and Procedural Variables in Predicting Bleeding After Percutaneous Coronary Intervention via the Femoral Approach: Development and Validation of a New Bleeding Risk Score.
    Mangiacapra F; Ricottini E; Barbato E; Demartini C; Peace A; Patti G; Vizzi V; De Bruyne B; Wijns W; Di Sciascio G
    Circ Cardiovasc Interv; 2015 May; 8(5):. PubMed ID: 25940521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematomas of at least 5 cm and outcomes in patients undergoing elective percutaneous coronary intervention: insights from the SafeTy and Efficacy of Enoxaparin in PCI patients, an internationaL randomized Evaluation (STEEPLE) trial.
    White HD; Aylward PE; Gallo R; Bode C; Steg G; Steinhubl SR; Montalescot G;
    Am Heart J; 2010 Jan; 159(1):110-6. PubMed ID: 20102875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients with non-ST-elevation acute coronary syndromes undergoing coronary artery bypass grafting in the modern era of antithrombotic therapy.
    Chew DP; Huang Z; Pieper KS; White H; Mahaffey KW; Ferguson JJ; Califf RM; Aylward PG
    Am Heart J; 2008 Feb; 155(2):239-44. PubMed ID: 18215592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized, blinded trial comparing fondaparinux with unfractionated heparin in patients undergoing contemporary percutaneous coronary intervention: Arixtra Study in Percutaneous Coronary Intervention: a Randomized Evaluation (ASPIRE) Pilot Trial.
    Mehta SR; Steg PG; Granger CB; Bassand JP; Faxon DP; Weitz JI; Afzal R; Rush B; Peters RJ; Natarajan MK; Velianou JL; Goodhart DM; Labinaz M; Tanguay JF; Fox KA; Yusuf S;
    Circulation; 2005 Mar; 111(11):1390-7. PubMed ID: 15781750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trial.
    Mehta SR; Granger CB; Eikelboom JW; Bassand JP; Wallentin L; Faxon DP; Peters RJ; Budaj A; Afzal R; Chrolavicius S; Fox KA; Yusuf S
    J Am Coll Cardiol; 2007 Oct; 50(18):1742-51. PubMed ID: 17964037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major bleeding complicating contemporary primary percutaneous coronary interventions-incidence, predictors, and prognostic implications.
    Fuchs S; Kornowski R; Teplitsky I; Brosh D; Lev E; Vaknin-Assa H; Ben-Dor I; Iakobishvili Z; Rechavia E; Battler A; Assali A
    Cardiovasc Revasc Med; 2009; 10(2):88-93. PubMed ID: 19327670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of multiple previous percutaneous coronary interventions in patients undergoing elective coronary artery bypass surgery.
    Thielmann M; Leyh R; Massoudy P; Neuhäuser M; Aleksic I; Kamler M; Herold U; Piotrowski J; Jakob H
    Circulation; 2006 Jul; 114(1 Suppl):I441-7. PubMed ID: 16820616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reoperation for bleeding in patients undergoing coronary artery bypass surgery: incidence, risk factors, time trends, and outcomes.
    Mehta RH; Sheng S; O'Brien SM; Grover FL; Gammie JS; Ferguson TB; Peterson ED;
    Circ Cardiovasc Qual Outcomes; 2009 Nov; 2(6):583-90. PubMed ID: 20031896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of outcome in patients undergoing PCI. Results of the RIVIERA study.
    Montalescot G; Ongen Z; Guindy R; Sousa A; Lu SZ; Pahlajani D; Pellois A; Vicaut E;
    Int J Cardiol; 2008 Oct; 129(3):379-87. PubMed ID: 18055032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized comparative study of using enoxaparin instead of unfractionated heparin in the intervention treatment of coronary heart disease.
    Chen JL; Chen J; Qiao SB; Guo YL; Wu YJ; Dai J; Yuan JQ; Qin XW; Yang YJ; Gao RL
    Chin Med J (Engl); 2006 Mar; 119(5):355-9. PubMed ID: 16542576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the Bleeding Academic Research Consortium definition of bleeding in patients with coronary artery disease undergoing percutaneous coronary intervention.
    Ndrepepa G; Schuster T; Hadamitzky M; Byrne RA; Mehilli J; Neumann FJ; Richardt G; Schulz S; Laugwitz KL; Massberg S; Schömig A; Kastrati A
    Circulation; 2012 Mar; 125(11):1424-31. PubMed ID: 22344040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.